Nuvalent deal delivers GSK’s first-ever lung cancer approval
In a landmark moment for its oncology ambitions, GSK has secured FDA approval for Jideytro (zidesamtinib) as the…
GSK FDA Approves Jideytro; 44% Response Rate
Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or…
GSK wins FDA nod for Jideytro lung cancer drug | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or…
AstraZeneca Pays $600M for Oral Pill That Beat Chemo in Rare Lung Cancer
For years, patients with a specific genomic subtype of lung cancer faced a stark choice: intravenous chemotherapy, or…
Surgery-Free Rectal Cancer Treatment Edges Closer as Dostarlimab Clears Registrational Trial
GSK announced Sunday that dostarlimab (Jemperli), its PD-1–blocking immunotherapy, met the primary endpoint of the AZUR-1 registrational Phase…
GSK (LSE:GSK) Wins FDA Approval For Utebzi As Momelotinib Gains Orphan Tag
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
GSK wins FDA approval for oral cUTI antibiotic | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
FDA approves GSK, Spero’s oral treatment for complicated UTIs
GSK and Spero Therapeutics have scored an FDA approval for Utebzi as the first oral carbapenem antibiotic for…
AstraZeneca’s New FDA Wins Raise Questions On Growth And Valuation
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…